(Q38006978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Retigabine for partial onset seizures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sylvain Rheims

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Sylvain Rheims

series ordinal

1

1 reference

26 August 2017

publication date

1 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

509-517

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

30 January 2020

cites work

1 reference

The pharmacological treatment of epilepsy in adults

21 January 2018

1 reference

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

Early identification of refractory epilepsy

21 January 2018

1 reference

The neurobehavioural comorbidities of epilepsy: can a natural history be developed?

21 January 2018

1 reference

Epilepsy and risk of suicide: a population-based case-control study

21 January 2018

1 reference

Sudden unexpected death in epilepsy: current knowledge and future directions

21 January 2018

1 reference

Mechanisms of epileptogenesis and potential treatment targets

21 January 2018

1 reference

21 January 2018

1 reference

Voltage-gated potassium channels as therapeutic targets

21 January 2018

1 reference

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

21 January 2018

1 reference

KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel

21 January 2018

1 reference

The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate

21 January 2018

1 reference

D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

21 January 2018

1 reference

D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures

21 January 2018

1 reference

Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study

21 January 2018

1 reference

Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).

21 January 2018

1 reference

Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers

21 January 2018

1 reference

Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects

21 January 2018

1 reference

Effects of age and sex on the disposition of retigabine

21 January 2018

1 reference

Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

21 January 2018

1 reference

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.

21 January 2018

1 reference

Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs.

21 January 2018

1 reference

Likelihood of seizure remission in an adult population with refractory epilepsy

21 January 2018

1 reference

Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis

21 January 2018

1 reference

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

21 January 2018

1 reference

Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy.

21 January 2018

1 reference

Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.12.33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22550979%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference